|POLISH FINANCIAL SUPERVISION AUTHORITY|
|UNI - EN REPORT No||38||/||2018|
|Date of issue:||2018-06-14|
|Short name of the issuer|
|Notification for acquisition of own shares|
|Official market - legal basis|
|art. 56. 1. 2 of Act on Public Offering.|
|Unofficial market - legal basis|
|Contents of the report:|
| Sopharma AD notifies that on 13 June 2018 the Company bought 24 062 own shares representing 0.0179% of the share capital of the Company, at a total value of 102 654.12 BGN on the Bulgarian Stock Exchange, the average price per share was 4.27 BGN.
The trading of treasury shares is pursuant to decision by the Extraordinary General Meeting of Shareholders from 23 February 2018.
The total number of treasury shares after these transactions is 9 064 828, representing 6.72% of the share capital of the Company.
|Current report 38 buy back 13062018 espi.pdfCurrent report 38 buy back 13062018 espi.pdf||Notification for acquisition of own shares|
|(fullname of the issuer)|
|SOPHARMA AD||Farmaceutyczny (far)|
|(short name of the issuer)|| (sector according to clasification
of the WSE in Warsow)
|+359 2 813 42 00||+359 2 936 02 86|
|SIGNATURE OF PERSONS REPRESENTING THE COMPANY|
|Date||Name||Position / Function||Signature|
|2018-06-14||Ognian Donev||Executive director|